Growth Metrics

Dna X (SONM) Non-Current Receivables (2022 - 2023)

Dna X's Non-Current Receivables history spans 2 years, with the latest figure at $7.9 million for Q3 2023.

  • Quarterly results put Non-Current Receivables at $7.9 million for Q3 2023, changed N/A from a year ago — trailing twelve months through Sep 2023 was $7.9 million (changed N/A YoY), and the annual figure for FY2022 was $6.8 million, changed.
  • Non-Current Receivables for Q3 2023 was $7.9 million at Dna X, up from $7.0 million in the prior quarter.
  • In the past five years, Non-Current Receivables ranged from a high of $7.9 million in Q3 2023 to a low of $6.8 million in Q4 2022.